United Kingdom· GB-APID-19172111000001106
Nalidixic acid 300mg/5ml oral suspension
A nalidixic acid product containing nalidixic acid, registered in United Kingdom by Rosemont Pharmaceuticals Ltd. The same ATC class is registered in 2 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Nalidixic acid is registered in 2 of 19 countries.
Countries holding a registration under ATC J01MB02 (nalidixic acid), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Nalidixic acid · ATC J01MB02
2 / 19 countries
- Finlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Nalidixic acid
- Manufacturer
- Rosemont Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- J01MB02
- ATC class
- Nalidixic acid
- Defined daily dose
- 4 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5016119036897
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
204 interactions on record for nalidixic acid.
Graded by severity as the source publishes them — 55 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nalidixic acid · interactions on record
204 records
- 55 severe
- 108 moderate
- 41 minor
Most severe, free to view
- PrednisoloneA07EA01severe
- HydrocortisoneA07EA02severe
- PrednisoneA07EA03severe
- BetamethasoneA07EA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nalidixic acid in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c753df8a-abe8-49f5-95aa-0ca192ef683c GET /v1/drugs/c753df8a-abe8-49f5-95aa-0ca192ef683c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "19172111000001106",
"desc": "Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)",
"form": "Oral suspension",
"vpid": "41952511000001106",
"source": "dmd",
"vtm_id": "776859002",
"strength": "60 mg",
"substance": "Nalidixic acid",
"ingredient": "Nalidixic acid",
"supplier_code": "2269501000001108"
}See everything about nalidixic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.